5378 Federal Register / Vol. 76, No. 20 / Monday, January 31, 2011 / Notices 

Dated: January 25, 2011. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–2013 Filed 1–28–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–11–11AC] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Using Traditional Foods and 

Sustainable Ecological Approaches for 

Health Promotion and Diabetes 

Prevention in American Indian/Alaska 

Native Communities—New—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Type 2 Diabetes was rare among 

American Indians until the 1950s. Since 

that time, diabetes has become one of 

the most common and serious illnesses 

among American Indians and Alaska 

Natives (AI/AN). From 1994 to 2004, the 

age-adjusted prevalence of diagnosed 

diabetes doubled (from 8.5 to 17.1 per 

1,000 population) among AI/ANs less 

than 35 years of age who used Indian 

Health Service healthcare services. 

However, dietary management and 

physical activity can help to prevent or 

control Type 2 diabetes. 

In 2008, the CDC’s Native Diabetes 

Wellness Program (NDWP), in 

consultation with American Indian/ 

Alaska Native Tribal elders, issued a 

cooperative agreement entitled, ‘‘Using 

Traditional Foods and Sustainable 

Ecological Approaches for Health 

Promotion and Diabetes Prevention in 

American Indian/Alaska Native 

Communities.’’ The Traditional Foods 

program seeks to build on what is 

known about traditional ways in order 

to inform culturally relevant, 

contemporary approaches to diabetes 

prevention for AI/AN communities. The 

program supports activities that 

enhance or re-introduce indigenous 

foods and practices drawn from each 

awardee’s landscape, history, and 

culture. Example activities include the 

cultivation of community gardens, 

organization of local farmers’ markets, 

and the dissemination of culturally 

appropriate health messages through 

storytelling, audio and video recordings, 

and printed materials. 

CDC requests OMB approval to collect 

standardized information, called 

Traditional Foods Shared Data Elements 

(SDE), from awardees over a three-year 

period. The SDE will be organized in 

three domains: Traditional Local 

Healthy Foods, Physical Activity, and 

Social Support for Healthy Lifestyle 

Change and Maintenance. Since each 

awardee currently maintains activity 

data for local program improvement, 

reporting summary information to CDC 

in SDE format is not expected to entail 

significant burden to respondents. 

The SDE will allow CDC to compile 

a systematic, quantifiable inventory of 

activities, products, and outcomes 

associated with the Traditional Foods 

program. The SDE will also allow CDC 

to analyze aggregate data for improved 

technical assistance and overall program 

evaluation, reporting, and identification 

of outcomes; allow CDC and awardees 

to create a comprehensive inventory/ 

resource library of diabetes primary 

prevention ideas and approaches for AI/ 

AN communities and identify emerging 

best practices; and improve 

dissemination of success stories. The 

annual Spring SDE submission will 

supplement the narrative progress 

report that awardees submit to CDC as 

part of the annual continuation 

application for funding. An additional 

SDE collection will be conducted 

annually in the Fall. 

Respondents will be 17 Tribes and 

Tribal organizations that receive 

funding through the Traditional Foods 

program. The estimated burden per 

response is two hours. The SDE will be 

reported using a Web-based survey 

interface. The total estimated burden for 

routine, semi-annual information 

collection is 68 hours. 

CDC also requests OMB approval to 

conduct one additional cycle of 

retrospective data collection during the 

first year of the three-year information 

collection request. The retrospective 

information collection will provide 

baseline SDE information about awardee 

activities that occurred in FY2010, 

which is needed for comparison 

purposes and optimal overall program 

evaluation. Inclusion of the 

retrospective data will enable CDC and 

awardees to have a clearer, more 

quantifiable view of the growth of 

Traditional Foods activities over the 

five-year funding cycle for the 

cooperative agreement. The estimated 

annualized burden for the one-time 

retrospective data collection is 12 hours. 

There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

80. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Avg. burden per 

response 

(in hrs) 

AI/AN Tribal Awardees ............................. Traditional Foods Shared Data Elements 17 2 2 

One-Time Retrospective Data Collection 6 1 2 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 20 / Monday, January 31, 2011 / Notices 5379 

Dated: January 24, 2011. 

Carol E. Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–2000 Filed 1–28–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Clinical Laboratory Improvement 

Advisory Committee (CLIAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

9:15 a.m.–5 p.m., March 2, 2011 

8:30 a.m.–12:30 p.m., March 3, 2011 

Place: CDC, 1600 Clifton Road, NE., 

Tom Harkin Global Communications 

Center, Building 19, Room 232, 

Auditorium B, Atlanta, Georgia 30333. 

Online Registration Required: In order 

to expedite the security clearance 

process at the CDC Roybal Campus 

located on Clifton Road, all CLIAC 

attendees are required to register for the 

meeting online at least 14 days in 

advance at http://wwwn.cdc.gov/cliac/ 

default.aspx by clicking the ‘‘Register for 

a Meeting’’ link and completing all 

forms according to the instructions 

given. Please complete all the required 

fields before submitting your 

registration and submit no later than 

February 16, 2011. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 100 

people. 

Purpose: This Committee is charged 

with providing scientific and technical 

advice and guidance to the Secretary, 

Department of Health and Human 

Services; the Assistant Secretary for 

Health; the Director, CDC; the 

Commissioner, Food and Drug 

Administration (FDA); and the 

Administrator, Centers for Medicare and 

Medicaid Services (CMS), regarding the 

need for, and the nature of, revisions to 

the standards under which clinical 

laboratories are regulated; the impact on 

medical and laboratory practice of 

proposed revisions to the standards; and 

the modification of the standards to 

accommodate technological advances. 

Matters To Be Discussed: The agenda 

will include agency updates from CDC, 

CMS, and FDA; presentations and 

discussions addressing activities of the 

Coordinating Council on the Clinical 

Laboratory Workforce; the National 

Institutes of Health Genetic Test 

Registry design and responses from 

testing laboratories; current testing 

practices and oversight of cytogenetic 

and cytogenomic testing; ongoing 

studies evaluating laboratory practices; 

and strategies for developing evidencebased methods for laboratory medicine 

quality improvement. 

Agenda items are subject to change as 

priorities dictate. 

Providing Oral or Written Comments: 

It is the policy of CLIAC to accept 

written public comments and provide a 

brief period for oral public comments 

whenever possible. 

Oral Comments: In general, each 

individual or group requesting to make 

an oral presentation will be limited to 

a total time of five minutes (unless 

otherwise indicated). Speakers must 

also submit their comments in writing 

for inclusion in the meeting’s Summary 

Report. To assure adequate time is 

scheduled for public comments, 

individuals or groups planning to make 

an oral presentation should, when 

possible, notify the contact person 

below at least one week prior to the 

meeting date. 

Written Comments: CLIAC accepts 

written comments until the date of the 

meeting (unless otherwise stated) for 

individuals or groups unable to attend 

the meeting. However, the comments 

should be received at least one week 

prior to the meeting date so that the 

comments may be made available to the 

Committee for their consideration and 

public distribution. Written comments 

and one hard copy with original 

signature should be provided to the 

contact person below. In addition, 

written comments will be included in 

the meeting’s Summary Report. 

Contact Person for Additional 

Information: Nancy Anderson, Chief, 

Laboratory Practice Standards Branch, 

Division of Laboratory Science and 

Standards, Laboratory Science, Policy 

and Practice Program Office (LSPPPO), 

Office of Surveillance, Epidemiology 

and Laboratory Services, CDC, 1600 

Clifton Road, NE., Mailstop F–11, 

Atlanta, Georgia 30333; telephone (404) 

498–2741; fax (404) 498–2219; or via email at Nancy.Anderson@cdc.hhs.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for the Centers 

for Disease Control and Prevention and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: January 25, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–1999 Filed 1–28–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Pregnancy 

Risk Assessment Monitoring System 

(PRAMS), DP11–001 Panels A, B, and 

C, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

7:30 p.m.–9 p.m., March 1, 2011 

(Closed) 

8:30 a.m.–7 p.m., March 2, 2011 

(Closed) 

8:30 a.m.–5 p.m., March 3, 2011 

(Closed) 

Place: Georgian Terrace Hotel, 659 

Peachtree Street, NE., Atlanta, GA 

30308, Telephone: (404) 898–8305. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

‘‘Pregnancy Risk Assessment Monitoring 

System (PRAMS), DP11–001 Panels A, 

B, and C.’’ 

Contact Person for More Information: 

Donald Blackman, Ph.D., Scientific 

Review Officer, CDC, National Center 

for Chronic Disease Prevention and 

Health Promotion, Office of the Director, 

Extramural Research Program Office, 

4770 Buford Highway, NE., Mailstop K– 

92, Atlanta, GA 30341, Telephone: (770) 

488–3023, E-mail: DBY7@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 


jlentini on DSKJ8SOYB1PROD with NOTICES